Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ADBE vs GSK✓SelectedUSD · GSKADBE vs GSK performance historyLatest closeAs of+1.20%11/16
Stock and ETF performance explorer

ADBE vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-63.3%
GSK return
+46.9%
Excess return
-110.2%
Maximum drawdown
-71.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+1.2%-0.1%+1.3%+1.2%
7D+3.7%-1.3%+5.0%+3.9%
30D+0.3%+2.7%-2.4%-0.2%
3M-6.8%+2.7%-9.5%-7.3%
6M-0.6%+3.3%-4.0%-1.3%
YTD-29.7%+6.5%-36.2%-31.0%
1Y-25.7%+10.7%-36.4%-27.7%
3Y-59.1%+64.4%-123.5%-64.4%
5Y-63.3%+46.7%-110.0%-72.1%
All-63.3%+46.9%-110.2%-72.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling